Bryostatin 1: all 42 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• Safety of Bryostatin in Patients With MSTerminatedNCT06190912Phase 1Results posted
• Bryostatin Treatment of Moderately Severe Alzheimer's DiseaseCompletedNCT04538066Phase 2Results posted
• A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's DiseaseCompletedNCT02431468Phase 2Results posted
• Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's DiseaseTerminatedNCT02221947Phase 1/2Results posted
• Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic CancerCompletedNCT00031694Phase 2Results posted
• Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach CancerCompletedNCT00006389Phase 2Results posted
• Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral TreatmentCompletedNCT02269605Phase 1
• A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)CompletedNCT00136461Phase 2
• Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00112476Phase 1
• Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00087425Phase 2
• Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell TransplantationCompletedNCT00058305Phase 2
• Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney CancerCompletedNCT00032188Phase 2
• Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related LymphomaCompletedNCT00022555Phase 1
• Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous LeukemiaCompletedNCT00017342Phase 2
• Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid CancerCompletedNCT00012376Phase 1
• Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00006942Phase 2
• Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach CancerCompletedNCT00006081Phase 2
• Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney CancerCompletedNCT00006022Phase 1
• Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the CervixCompletedNCT00005965Phase 2
• Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung CancerCompletedNCT00005849Phase 2
• Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach CancerCompletedNCT00005599Phase 2
• Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's LymphomaCompletedNCT00005580Phase 1
• Bryostatin 1 In Treating Patients With Progressive Kidney CancerCompletedNCT00005056Phase 2
• Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate CancerCompletedNCT00005028Phase 2
• Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced CancerCompletedNCT00004144Phase 1
• Bryostatin 1 in Treating Patients With Ovarian Epithelial CancerCompletedNCT00004008Phase 2
• Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or LymphomaCompletedNCT00003993Phase 1
• Bryostatin 1 in Treating Patients With Metastatic Kidney CancerCompletedNCT00003968Phase 2
• Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's DiseaseCompletedNCT00003936Phase 2
• Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck CancerCompletedNCT00003443Phase 2
• Bryostatin 1 Plus Paclitaxel and Cisplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00003242Phase 1
• Bryostatin 1 in Treating Patients With Metastatic Colorectal CancerCompletedNCT00003220Phase 2
• Bryostatin 1 in Treating Patients With Stage IV Breast CancerCompletedNCT00003205Phase 2
• Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaCompletedNCT00003174Phase 1
• Bryostatin 1 in Treating Patients With Myelodysplastic SyndromeCompletedNCT00003171Phase 2
• Bryostatin and Vincristine in B-Cell MalignanciesCompletedNCT00003166Phase 1
• Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable CancerCompletedNCT00003132Phase 1
• Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced CancerCompletedNCT00003108Phase 1
• Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or LymphomaCompletedNCT00003079Phase 1
• Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00002908Phase 2
• Bryostatin 1 in Treating Patients With Relapsed Multiple MyelomaCompletedNCT00002907Phase 2
• Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's LymphomaCompletedNCT00002725Phase 2

← Bryostatin 1 overview